Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,798 total articles
Kymera Therapeutics, a clinical-stage biotech company specializing in oral small molecule degraders for immunological diseases, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026. The event highlights Kymera's progress in pioneering targeted protein degradation as a novel therapeutic approach.
Lantronix Inc., a provider of Edge AI and Industrial IoT solutions, announced its preliminary addition to the Russell 3000 Index as part of the 2026 Russell indexes reconstitution. This inclusion is reflective of the company's strategic repositioning towards higher-growth and higher-value markets and is expected to enhance its visibility to institu…
BioCryst Pharmaceuticals announces seven abstracts from its hereditary angioedema (HAE) portfolio to be presented at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting. The data focus on ORLADEYO (berotralstat), the first oral prophylactic therapy for HAE, and navenibart, an investigational monoclonal antibody for attack pr…
Korro Bio, a biopharmaceutical company specializing in RNA editing genetic medicines via its OPERA platform, announced CEO Ram Aiyar will present at the 2026 Jefferies Global Healthcare Conference. The presentation highlights Korro's innovative approach to developing treatments for rare and prevalent diseases by precisely editing RNA to enhance the…
X4 Pharmaceuticals, focused on innovative therapies for rare hematology diseases, announced its management will present at the 2026 Jefferies Global Healthcare Conference. The company specializes in CXCR4 biology and has an approved drug, XOLREMDI®, for WHIM syndrome. It is currently conducting a pivotal Phase 3 trial for mavorixafor in chronic neu…
NRx Pharmaceuticals announced that its subsidiary, HOPE Therapeutics, has become the first commercial site to use Zeta Surgical's FDA-cleared Zeta TMS Navigation System at its West Palm Beach clinic. The system integrates AI-powered, sub-millimetric image guidance to improve precision in Transcranial Magnetic Stimulation (TMS) treatment for major d…
Village Farms International, a leading cannabis cultivator and distributor, received the Producer of the Year award at the 2026 Business of Cannabis Awards in London, recognizing its excellence in cultivation, sustainability, and compliance. The company is expanding internationally with the world's largest EU-GMP certified cannabis facility in Brit…
Beamr Imaging Ltd. issued a Q1-2026 CEO letter highlighting progress in AI-based video compression technology across media & entertainment and autonomous vehicle markets. The company demonstrated its content-adaptive compression in partnership with VAST Data and dSPACE, validated enhanced machine learning model robustness from compressed video, and…
Sharps Technology, Inc. has rebranded to SkyAI, Inc. and will trade on Nasdaq under the ticker 'SKYA'. The company is transitioning into building a category-defining agentic finance platform aimed at serving the Global South—emerging markets in Asia, Latin America, and Africa. SkyAI plans to leverage AI, stablecoins, and the Solana blockchain to pr…
Following the 2026 Annual General Meeting in Amsterdam, STMicroelectronics appointed Mr. Armando Varricchio as Chairman and Mr. Nicolas Dufourcq as Vice-Chairman of its Supervisory Board, with terms lasting until 2029. The company continues to emphasize its commitment to semiconductor innovation and sustainability goals, including carbon neutrality…
ANI Pharmaceuticals announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 3, 2026. The event aims to showcase the company's commitment to innovative therapeutics and growth across its Rare Disease, Generics, and Brands business sectors.
Bath & Body Works reported first quarter 2026 net sales of $1.4 billion, a 3% decline year-over-year, with adjusted earnings per share of $0.32 exceeding guidance. The company reaffirmed full-year 2026 guidance projecting net sales decline between 4.5% to 2.5% and adjusted EPS between $2.40 and $2.65. Leadership changes include CFO Eva Boratto step…
Scorpio Tankers Inc. has entered agreements to sell four LR2 product tankers for $285.8 million and signed a letter of intent to purchase two scrubber-fitted MR product tankers, expected for delivery in 2030. Additionally, the company plans to prepay approximately $367.8 million of secured debt due in 2028, leading to the termination of several cre…
At the 2026 Annual General Meeting held in Amsterdam, STMicroelectronics announced unanimous shareholder approval on all resolutions, including adoption of 2025 financial accounts, a $0.36 per share cash dividend payable quarterly, reappointment of board member Frédéric Sanchez, approval of stock-based executive compensation, share repurchase autho…
KANZHUN LIMITED (BOSS Zhipin) announced ongoing share repurchases totaling over RMB1.48 billion in 2026, with a recent purchase of approximately 600,854 shares worth RMB27 million. The company increased its authorized share repurchase program to US$400 million through August 2027. Additionally, it commit to allocate at least 50% of adjusted net inc…
Apogee Therapeutics announced a strategic financing collaboration with Blackstone Life Sciences, gaining up to $1.3 billion in flexible, non-dilutive capital to support the late-stage development and commercialization of its leading product candidate, Zumilokibart, targeting moderate-to-severe atopic dermatitis and other inflammatory and immunology…
Apogee Therapeutics announced highly positive 16-week results from Part B of its Phase 2 APEX clinical trial evaluating Zumilokibart, an anti-IL-13 antibody, in patients with moderate-to-severe atopic dermatitis. The trial met all primary and secondary endpoints with strong statistical significance, demonstrating robust efficacy and a favorable saf…
PDD Holdings Inc. announced its unaudited financial results for Q1 2026, showing an 11% increase in total revenues to RMB106.2 billion (US$15.4 billion) and a 22% increase in operating profit to RMB19.6 billion (US$2.8 billion) compared to the same quarter in 2025. Despite these gains, net income attributable to ordinary shareholders declined by 15…
Nano Dimension has entered into a definitive agreement to sell its wholly owned subsidiary MarkForged, Inc. to Stratasys Ltd. in an all-cash transaction worth $42.5 million. This sale is a key part of Nano Dimension's three-phase strategic plan aimed at maximizing long-term shareholder value. The transaction is expected to reduce Nano Dimension's a…
Radware Ltd., a NASDAQ-listed leader in application security and delivery for multi-cloud environments, reported that all three proposals submitted at its 2026 Annual General Meeting were approved by shareholders. The company reaffirmed its leadership in AI-driven cybersecurity solutions and outlined the usual risks and forward-looking statements r…
AtaiBeckley Inc., a clinical-stage biotech company focused on innovative mental health treatments, announced its participation in several investor conferences throughout June 2026. Management will present company updates and pipeline progress in fireside chats and one-on-one meetings, with webcasts available to the public. The company's pipeline in…
Gran Tierra Energy Inc. has completed all conditions precedent to earn a 49% working interest in the Tisquirama block in Colombia, adjacent to its existing operated Acordionero field. The company plans Phase 1 capital investment focusing on waterflood expansion and well optimization to enhance oil recovery, with expected synergies from integrated w…
Enerflex Ltd. has published its 2026 Investor Update presentation focusing on its strategy to prioritize operational excellence, targeted growth in attractive natural gas and power markets, and disciplined capital allocation. The company aims to improve adjusted EBITDA margin, cash conversion ratio, and ROCE by over 200 basis points over a full cyc…
Ellomay Capital Ltd., an international renewable energy developer and power generator, disclosed its Q1 2026 financial results showing a loss of €12.2 million compared to a profit of €6.8 million in Q1 2025. Revenues decreased slightly to €8.7 million mainly due to lower electricity prices in key European markets. The company completed the sale of …
Colliers has successfully acquired Ayesa Engineering, a global multidisciplinary engineering and project management firm based in Spain. This acquisition boosts Colliers Engineering's workforce to over 11,000 professionals across 23 countries and enhances its capabilities in property, infrastructure, water, and environmental sectors. The move under…
